J. Rosas

发表

Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.

M. García-Carrasco, M. Ramos-Casals, J. Font, 2002, Rheumatology.

Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics

M. García-Carrasco, M. Ramos-Casals, J. Font, 1999, Lupus.

Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients

M. García-Carrasco, R. Cervera, M. Ramos-Casals, 2002, Medicine.

Primary Sjögren Syndrome: Hematologic Patterns of Disease Expression

M. García-Carrasco, R. Cervera, M. Ramos-Casals, 2002, Medicine.

Primary Sjögren Syndrome in Spain: Clinical and Immunologic Expression in 1010 Patients

J. Jiménez-Alonso, M. Ramos-Casals, R. Solans, 2008, Medicine.

Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome

M. Fernandez Castro, J. Andreu, J. Rosas, 2020, Rheumatology International.

Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

P. Carreira, J. Rosas, A. Fernández-Nebro, 2015, Medicine.

Comparison of manual and automated cell counts in EDTA preserved synovial fluids. Storage has little influence on the results

J. Rosas, E. Pascual, M. Salinas, 1997, Annals of the rheumatic diseases.

Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis

L. Carmona, J. Rosas, R. Sanmartí, 2020 .

Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review

L. Carmona, J. Rosas, R. Sanmartí, 2018, Rheumatology International.

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

J. Andreu, J. Rosas, A. Fernández-Nebro, 2016, Medicine.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

P. Carreira, J. Andreu, I. Millán, 2017, Reumatologia clinica.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

P. Carreira, J. Andreu, I. Millán, 2019, Reumatología Clínica (English Edition).

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study

M. Fernandez Castro, J. Andreu, J. Rosas, 2017, Arthritis care & research.

Systemic autoimmune diseases co‐existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases

J. Anaya, M. Ramos-Casals, J. Font, 2005, Journal of internal medicine.

Cutaneous Vasculitis in Primary Sjögren Syndrome: Classification and Clinical Significance of 52 Patients

J. Anaya, M. García-Carrasco, M. Ramos-Casals, 2004, Medicine.

Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

E. de Miguel, J. Rosas, P. Zarco, 2016, Arthritis care & research.

FRI0408 Analysis of Disease Activity and Response to Treatment in A Large Cohort from the Spanish Society of Rheumatology Registry of Patients with Systemic Lupus Erythematosus (RELESSER)

J. Rosas, A. Fernández-Nebro, E. Loza, 2014 .

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study.

M. González-Gay, L. Rodríguez-Rodríguez, J. Nolla, 2017, Reumatologia clinica.

Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

M. García-Carrasco, J. Rosas, F. Llinares-Tello, 2017, Clinical and experimental rheumatology.

Sjögren Syndrome Associated With Hepatitis C Virus: A Multicenter Analysis of 137 Cases

J. Anaya, M. Zeher, S. De Vita, 2005, Medicine.

Hepatitis C Virus Infection Mimicking Primary Sjögren Syndrome: A Clinical and Immunologic Description of 35 Cases

M. García-Carrasco, R. Cervera, M. Ramos-Casals, 2001, Medicine.

Whipple’s disease diagnosed during anti-tumor necrosis factor alpha treatment: two case reports and review of the literature

J. Rosas, A. Gutiérrez, J. Ramos, 2015, Journal of Medical Case Reports.

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning

J. C. Nieto‐González, J. Rosas, J. Cañete, 2022, Arthritis Research & Therapy.

FRI0413 Comorbidity in a Cohort of Primary Sjögren's Syndrome Patients

M. Fernandez Castro, J. Rosas, S. Manrique-Arija, 2015 .

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry.

J. Rosas, J. M. Senabre-Gallego, G. Santos-Soler, 2020, Reumatologia clinica.

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry.

J. Rosas, J. Bernal, J. M. Senabre-Gallego, 2020, Reumatologia clinica.

Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry.

P. Carreira, M. Fernandez Castro, J. Andreu, 2020, Clinical and experimental rheumatology.

A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.

X. Mariette, J. Gottenberg, V. Devauchelle-Pensec, 2020, Rheumatology.

Renal Involvement In Primary Sjögren’s Syndrome: Data From The Spanish Sjögrenser Cohort.

J. Andreu, J. Rosas, C. Sánchez-Piedra, 2020 .

Key words: Sjögren’s syndrome, renal disease, tubulointerstitial nephritis, renal tubular dysfunction, glomerulonephritis

J. Andreu, J. Rosas, C. Sánchez-Piedra, 2020 .

ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts

J. Andreu, J. Rosas, A. Olivé, 2019, Rheumatology International.

Factors associated with severe dry eye in primary Sjögren’s syndrome diagnosed patients

M. Fernandez Castro, J. Andreu, J. Rosas, 2018, Rheumatology International.

Sjögren SER: National registry of the Spanish Society of Rheumatology of patients with primary Sjögren syndrome: Objectives and methodology.

M. Fernandez Castro, J. Andreu, J. Rosas, 2016 .

Identification of lymphoma predictors in patients with primary Sjögren’s syndrome: a systematic literature review and meta-analysis

J. Andreu, J. Rosas, J. Pego-Reigosa, 2014, Rheumatology International.

Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.

M. García-Carrasco, R. Cervera, M. Ramos-Casals, 2002, The Journal of rheumatology.

Synovial Fluid Analysis for Diagnosis of Intercritical Gout

E. Batlle-Gualda, J. Rosas, P. Vela, 1999, Annals of Internal Medicine.

Acute bacterial arthritis caused by group C streptococci.

J. Rosas, J. Calvo-Alén, M. P. Roiz, 2001, Seminars in arthritis and rheumatism.

Gastrointestinal Involvement in Primary Sjögren’s Syndrome

P. Szodoray, M. Zeher, M. Ramos-Casals, 2011 .

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis

M. Sánchez‐Barrioluengo, J. Rosas, X. Barber, 2013, Patient preference and adherence.

Systemic Autoimmune Diseases in Patients with Hepatitis C Virus Infection: Characterization of 1020 Cases (The HISPAMEC Registry)

X. Forns, J. Sánchez-Tapias, M. Ramos-Casals, 2009, The Journal of Rheumatology.

Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study)

J. Rosas, E. Collantes Estévez, A. Alonso Ruiz, 2017, Rheumatology International.

Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

M. Ruiz-Argüello, D. Nagore, J. Rosas, 2016, Annals of the rheumatic diseases.

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER).

P. Carreira, J. Rosas, A. Fernández-Nebro, 2020, Rheumatology.

THU0137 Non-Adherence To Subcutaneous Biological Therapy in Patients with Rheumatoid Arthritis. Arco Study

J. Rosas, J. Tovar Beltrán, J. Calvo-Alén, 2016 .

Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).

J. Andreu, J. Rosas, A. Olivé, 2017, Clinical and experimental rheumatology.

Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis

M. García-Carrasco, J. Rosas, G. Santos-Soler, 2019, Rheumatology International.

Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

J. Rosas, I. de la Torre, C. Santos-Ramírez, 2014, Clinical and experimental rheumatology.

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

J. C. Nieto‐González, J. Rosas, J. Tasende, 2019, Reumatología Clínica (English Edition).

Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study

L. Abasolo, M. González-Gay, J. Nolla, 2020, Arthritis care & research.

One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial

E. Gómez-Barrena, F. Navarro, J. Rosas, 2021, Journal of pain research.

Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).

J. Andreu, J. Alcázar, J. Rosas, 2023, Seminars in arthritis and rheumatism.

Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison.

J. Yagüe, E. Naredo, J. Garrido, 2015, Clinical and Experimental Rheumatology.

Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study

J. Rosas, R. Sanmartí, A. Balsa, 2018, Rheumatology.

AB0396 Infliximab and Adalimumab Levels and Antidrug Antibodies Detection in Patients with Rheumatoid Arthritis (RA): an Interlaboratory Comparison Using A Commercial ELISA Assay

E. Naredo, J. Rosas, I. de la Torre, 2014 .

FRI0197 Adherence, satisfaction and fulfillment of expectations of patients with rheumatoid arthritis treated with subcutaneous biologicals. arco study

J. Rosas, C. Marras, J. Calvo-Alén, 2017 .

FRI0295 ADALIMUMAB LEVELS ARE ASSOCIATED WITH DRUG RETENTION RATES IN AXIAL SPONDYLOARTHRITIS PATIENTS

J. Rosas, J. Bernal, J. Molina, 2020 .

Comparative study of both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab in rheumatoid arthritis.

J. Rosas, I. de la Torre, X. Barber, 2014, Reumatologia clinica.

FRI0130 Clinical and Imaging Differences between Patients with Familial Early Axial Spondiloarthritis and Sporadic Forms: Results from Esperanza Cohort

J. Rosas, P. Zarco, V. Navarro-Compán, 2014 .

Practical Aspects of Biological Throughput Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis.

L. Carmona, J. Rosas, R. Sanmartí, 2020, Reumatologia clinica.

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

L. Carmona, J. Rosas, C. Marras, 2017, Clinical and experimental rheumatology.

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.

P. Trenor Larraz, J. C. Nieto‐González, Martina Steiner, 2019, Reumatologia clinica.